Fig. 7.
Results of the deterministic sensitivity analysis for mirabegron 50 mg versus a solifenacin 5/10 mg and b oxybutynin IR 5 mg (incremental cost per patient per day). All doses reported are the total dose per day. IR immediate release
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.